Vertex Pharmaceuticals Should Earn An Expanded Label For Its Lead Blockbuster Drug Seeking Alpha, 29 Aug 2016 Vertex Pharmaceuticals (NASDAQ: VRTX ) is a large (market cap of $25.01 billion) global biotechnology company with two products…